US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Decoy Therapeutics Inc

1.07

-0.1600-13.01%

Post-market: 1.080.0100+0.93%19:33 EDT

Volume:117.14K

Turnover:136.80K

Market Cap:2.55M

PE:-0.03

High:1.23

Open:1.21

Low:1.05

Close:1.23

52wk High:47.28

52wk Low:0.9000

Shares:2.39M

Float Shares:2.32M

Volume Ratio:2.33

T/O Rate:5.06%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-40.3963

EPS(LYR):-129.1004

ROE:-827.77%

ROA:-73.35%

PB:0.59

PE(LYR):-0.01

Loading ...

Overview Company News Filings

Decoy Therapeutics - Files Prospectus for Resale of up to 2,368,868 Common Shares - SEC Filing

THOMSON REUTERS

Decoy Therapeutics CEO Rick Pierce Presents at Small Cap Showcase

Decoy Therapeutics Says Preclinical PK Data Support Once-Weekly Intranasal Dosing for DCOY-CoV Program

Decoy Therapeutics Corrects Warrant Inducement Release, Says New Warrants Exercisable on Issuance

Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release

Decoy Therapeutics Enters Warrant Inducement Deal for $3.85 Million; Shares Rise

MT Newswires Live

Why Is Penny Stock Decoy Therapeutics (DCOY) Up 48% Today?

Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-the-Market Under NASDAQ Rules

THOMSON REUTERS

NASDAQ Trade Halt Volatility Trading Pause at 12:51 Pm

Decoy Therapeutics Issues Warrants for 2,368,868 Shares at USD 3.25 Each

U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify

Decoy Therapeutics to explore pan-filovirus program via FDA Animal Rule pathway

Decoy Therapeutics Says Next-Generation D-MAVs Show in Vitro Activity Against Ebola Zaire, Marburg Viruses

Decoy Therapeutics Holds Special Shareholder Meeting with Quorum Present

Decoy Therapeutics Q2 Net Loss Widens 148% to $2.37 Million; Revenue Turns to $227,629 from no Revenue

Decoy Therapeutics Announces Special Shareholder Meeting Via Webcast

Decoy Therapeutics Expands IP Portfolio with 1 Granted US Patent, 19 Applications Pending

Decoy Therapeutics Files Form 3 for Director Patricia G. Gauthier

Decoy Therapeutics D-MAV Candidate Shows in Vitro Activity Against Ebola Zaire Virus

Decoy Therapeutics Announces Special Shareholder Meeting

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/stock/DCOY/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"DCOY","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","market":"US","secType":"STK","nameCN":"Decoy Therapeutics Inc","latestPrice":1.07,"timestamp":1793390400000,"preClose":1.23,"halted":0,"volume":117136,"hourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.07,"latestTime":"19:33 EDT","volume":1186,"amount":1281.5463,"timestamp":1793403214092,"change":0.01,"changeRate":0.009346,"amplitude":0.018692},"delay":0,"changeRate":-0.13008130081300806,"floatShares":2316500,"shares":2385300,"eps":-40.396286,"marketStatus":"Market Closed","change":-0.16,"latestTime":"10-30 16:00:00 EDT","open":1.21,"high":1.23,"low":1.05,"amount":136796.6802064,"amplitude":0.146341,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-40.396286,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1793610000000},"marketStatusCode":7,"adr":0,"listingDate":1422507600000,"exchange":"NASDAQ","adjPreClose":1.23,"preHourTrading":{"tag":"盘前","latestPrice":1.21,"preClose":1.23,"latestTime":"09:29 EDT","volume":11878,"amount":14431.6595346,"timestamp":1793366970100,"change":-0.02,"changeRate":-0.01626,"amplitude":0.053659},"postHourTrading":{"tag":"盘后","latestPrice":1.08,"preClose":1.07,"latestTime":"19:33 EDT","volume":1186,"amount":1281.5463,"timestamp":1793403214092,"change":0.01,"changeRate":0.009346,"amplitude":0.018692},"volumeRatio":2.33081420106098},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"DCOY\",,,,,undefined,":{"symbol":"DCOY","floatShares":2316500,"roa":"-73.35%","roe":"-827.77%","lyrEps":-129.100415,"volumeRatio":2.33081420106098,"shares":2385300,"dividePrice":0,"high":1.23,"amplitude":0.146341,"preClose":1.23,"low":1.05,"week52Low":0.9,"pbRate":"0.59","psRate":"11.21","week52High":47.28,"institutionHeld":0,"latestPrice":1.07,"eps":-40.396286,"divideRate":0,"volume":117136,"delay":0,"ttmEps":-40.396286,"open":1.21,"prevYearClose":7.7856,"prevWeekClose":0.97,"prevMonthClose":1.97,"prevQuarterClose":1.97,"fiveDayClose":0.97,"twentyDayClose":1.77,"sixtyDayClose":4.06},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/DCOY\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-12","symbol":"DCOY","fiscalQuarterEnding":"2026/06","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786507200000,"reportTimeType":"post","actualEps":-4.46},{"market":"US","date":"2026-05-08","symbol":"DCOY","fiscalQuarterEnding":"2026/03","expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1778212800000,"reportTimeType":"post","actualEps":-4.18},{"market":"US","date":"2026-03-31","symbol":"DCOY","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1774929600000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2026-03-09","symbol":"DCOY","defaultRemindTime":1773063000000,"type":"split","dateTimestamp":1773028800000,"forFactor":12,"toFactor":1,"ratio":12}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"DCOY\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"DCOY\",market:\"US\",delay:false,,,undefined,":{"strongBuy":1,"buy":0,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":1,"analysts":1,"updateTime":1790827200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/DCOY\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"DCOY","date":"2026-10-14","current":-0.026488,"percent":1,"low":-1.594527,"twenty":-0.8485,"median":-0.248169,"eighty":-0.141833,"high":-0.056225,"avg":-0.421096,"sd":0.346131,"marketCap":812429},"quantilePoints":[{"date":"2026-01-09","current":-0.982229,"twenty":-1.053663,"median":-1.026876,"eighty":-1.000088,"marketCap":4915816},{"date":"2026-01-16","current":-1.227403,"twenty":-1.203881,"median":-1.071522,"eighty":-1.040856,"marketCap":6142855},{"date":"2026-01-23","current":-0.957354,"twenty":-1.160688,"median":-1.045754,"eighty":-0.982229,"marketCap":4791324},{"date":"2026-01-30","current":-1.05749,"twenty":-1.109791,"median":-1.050666,"eighty":-0.994985,"marketCap":5292482},{"date":"2026-02-06","current":-0.790885,"twenty":-1.101882,"median":-1.039631,"eighty":-0.91832,"marketCap":3958189},{"date":"2026-02-13","current":-0.956844,"twenty":-1.071522,"median":-0.994921,"eighty":-0.926101,"marketCap":4788771},{"date":"2026-02-20","current":-1.018456,"twenty":-1.060296,"median":-0.989117,"eighty":-0.939163,"marketCap":5097126},{"date":"2026-02-27","current":-0.871249,"twenty":-1.05596,"median":-0.982229,"eighty":-0.908242,"marketCap":4360392},{"date":"2026-03-06","current":-0.74305,"twenty":-1.047719,"median":-0.957099,"eighty":-0.869974,"marketCap":3718783},{"date":"2026-03-13","current":-0.796199,"twenty":-1.041162,"median":-0.954292,"eighty":-0.863596,"marketCap":3984784},{"date":"2026-03-20","current":-0.84935,"twenty":-1.039708,"median":-0.934265,"eighty":-0.844716,"marketCap":4250791},{"date":"2026-03-27","current":-0.746769,"twenty":-1.027385,"median":-0.915268,"eighty":-0.830428,"marketCap":3737398},{"date":"2026-04-02","current":-0.671826,"twenty":-1.020803,"median":-0.90314,"eighty":-0.800664,"marketCap":3362328},{"date":"2026-04-10","current":-0.254968,"twenty":-1.004373,"median":-0.87465,"eighty":-0.787058,"marketCap":3191808},{"date":"2026-04-17","current":-0.249443,"twenty":-0.994908,"median":-0.869974,"eighty":-0.73327,"marketCap":3122652},{"date":"2026-04-24","current":-0.230321,"twenty":-0.987969,"median":-0.855197,"eighty":-0.507377,"marketCap":2883266},{"date":"2026-05-01","current":-0.257092,"twenty":-0.982688,"median":-0.845098,"eighty":-0.256242,"marketCap":3218406},{"date":"2026-05-08","current":-0.243919,"twenty":-0.982229,"median":-0.84006,"eighty":-0.250421,"marketCap":3053496},{"date":"2026-05-15","current":-0.184485,"twenty":-0.974422,"median":-0.810018,"eighty":-0.248296,"marketCap":2404495},{"date":"2026-05-22","current":-0.262442,"twenty":-0.962099,"median":-0.79992,"eighty":-0.247659,"marketCap":3420554},{"date":"2026-05-29","current":-0.322848,"twenty":-0.95715,"median":-0.794073,"eighty":-0.248169,"marketCap":4207866},{"date":"2026-06-05","current":-0.27387,"twenty":-0.956742,"median":-0.781317,"eighty":-0.248169,"marketCap":3569505},{"date":"2026-06-12","current":-0.24081,"twenty":-0.95567,"median":-0.74491,"eighty":-0.247404,"marketCap":3138611},{"date":"2026-06-18","current":-0.24285,"twenty":-0.952787,"median":-0.706406,"eighty":-0.245537,"marketCap":3165209},{"date":"2026-06-26","current":-0.241544,"twenty":-0.945899,"median":-0.6697,"eighty":-0.244973,"marketCap":3148186},{"date":"2026-07-02","current":-0.311012,"twenty":-0.942429,"median":-0.364072,"eighty":-0.244891,"marketCap":4053596},{"date":"2026-07-10","current":-0.255707,"twenty":-0.926101,"median":-0.334889,"eighty":-0.244891,"marketCap":3332779},{"date":"2026-07-17","current":-0.244483,"twenty":-0.91832,"median":-0.322848,"eighty":-0.24285,"marketCap":3186488},{"date":"2026-07-24","current":-0.201627,"twenty":-0.915268,"median":-0.304685,"eighty":-0.239993,"marketCap":2627921},{"date":"2026-07-31","current":-0.159996,"twenty":-0.910668,"median":-0.29693,"eighty":-0.235273,"marketCap":2085314},{"date":"2026-08-07","current":-0.16571,"twenty":-0.904416,"median":-0.286523,"eighty":-0.233302,"marketCap":2159790},{"date":"2026-08-14","current":-0.129959,"twenty":-0.896201,"median":-0.26684,"eighty":-0.229711,"marketCap":1877847},{"date":"2026-08-21","current":-0.148725,"twenty":-0.881334,"median":-0.262442,"eighty":-0.225153,"marketCap":2149006},{"date":"2026-08-28","current":-0.134668,"twenty":-0.872609,"median":-0.257114,"eighty":-0.215096,"marketCap":1945899},{"date":"2026-09-04","current":-0.130588,"twenty":-0.870229,"median":-0.255393,"eighty":-0.199995,"marketCap":1886932},{"date":"2026-09-11","current":-0.123786,"twenty":-0.869974,"median":-0.254968,"eighty":-0.182689,"marketCap":1788655},{"date":"2026-09-18","current":-0.12832,"twenty":-0.869208,"median":-0.250612,"eighty":-0.16971,"marketCap":1854173},{"date":"2026-09-25","current":-0.141017,"twenty":-0.862829,"median":-0.250293,"eighty":-0.16473,"marketCap":2037625},{"date":"2026-10-02","current":-0.084111,"twenty":-0.854452,"median":-0.249179,"eighty":-0.157302,"marketCap":1215368},{"date":"2026-10-09","current":-0.068921,"twenty":-0.8502,"median":-0.248169,"eighty":-0.148009,"marketCap":995881},{"date":"2026-10-14","current":-0.056225,"twenty":-0.8485,"median":-0.248169,"eighty":-0.141833,"marketCap":812429}],"updateTime":1793501394450},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"DCOY\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673048406","title":"Decoy Therapeutics - Files Prospectus for Resale of up to 2,368,868 Common Shares - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673048406","media":"THOMSON REUTERS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673048406?lang=en_us&edition=fundamental","pubTime":"2026-10-08 05:00","pubTimestamp":1791406825,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20261007:nFWN45T12M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671149204","title":"Decoy Therapeutics CEO Rick Pierce Presents at Small Cap Showcase","url":"https://stock-news.laohu8.com/highlight/detail?id=2671149204","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671149204?lang=en_us&edition=fundamental","pubTime":"2026-09-30 20:33","pubTimestamp":1790771614,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics CEO Rick Pierce presents at Small Cap ShowcaseDecoy Therapeutics will present at The Small Cap Showcase on Oct. 1, 2026 in New York.CEO Rick Pierce is scheduled to deliver a corpora","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260930:nNDLQbVQB:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BN0W2V16.EUR","IE00BN0W2W23.USD","IE00BQXX3C00.GBP","SG9999014039.USD","BK4585","BK4112","LU2210149790.SGD","IE00BKPKM429.USD","IE00BQXX3F31.USD","IE00B3QW5Z07.USD","BK4139","SG9999014013.SGD","LU2095319765.USD","IE00BN0W2T93.GBP","LU0314104364.USD","IE00B64PRP62.GBP","BK4588","NDAQ","SG9999014005.SGD","IE00BQXX3D17.EUR","DCOY","IE00BGHQF748.EUR","BCDF","SG9999014021.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671193132","title":"Decoy Therapeutics Says Preclinical PK Data Support Once-Weekly Intranasal Dosing for DCOY-CoV Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671193132","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671193132?lang=en_us&edition=fundamental","pubTime":"2026-09-29 19:31","pubTimestamp":1790681478,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics says preclinical PK data support once-weekly intranasal dosing for DCOY-CoV programDecoy Therapeutics released preclinical PK data supporting once-weekly intranasal dosing for lead ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260929:nNDL99fWH2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669206671","title":"Decoy Therapeutics Corrects Warrant Inducement Release, Says New Warrants Exercisable on Issuance","url":"https://stock-news.laohu8.com/highlight/detail?id=2669206671","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669206671?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:15","pubTimestamp":1790115313,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics corrects warrant inducement release, says new warrants exercisable on issuanceDecoy Therapeutics corrected a Sept. 22, 2026 release on its warrant inducement transaction.New unregis","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL7DnvPt:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669206701","title":"Press Release: Decoy Therapeutics, Inc. Issues Correction to Warrant Inducement Transaction Press Release","url":"https://stock-news.laohu8.com/highlight/detail?id=2669206701","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669206701?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:14","pubTimestamp":1790115240,"startTime":"0","endTime":"0","summary":"HOUSTON, Sept. 22, 2026 /PRNewswire/ -- Decoy Therapeutics, Inc. (NASDAQ: DCOY) (the \"Company\" or \"Decoy\"), today issued a correction to its press release dated September 22, 2026 announcing the Compa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4555","TM","DCOY","BK4139","BK4007","BK4539","BK4585","BK4099","BK4588","LENZ","BK4604","03160"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669298341","title":"Decoy Therapeutics Enters Warrant Inducement Deal for $3.85 Million; Shares Rise","url":"https://stock-news.laohu8.com/highlight/detail?id=2669298341","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669298341?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:24","pubTimestamp":1790097892,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics  entered into a warrant inducement agreement with an existing institutional investor that is expected to generate $3.85 million in gross proceeds.Under the agreement, the undisclosed investor will exercise 1.18 million Series B milestone warrants at a reduced price of $3.25 a share, Decoy said Tuesday in a statement. The exercise prices of the company's outstanding Series A and Series C milestone warrants will also be cut to $3.25 from $5.91.In exchange for the immediate exercise, the investor will receive new warrants to purchase up to 2.37 million shares at $3.25 each, subject to stockholder approval before they become exercisable.The company plans to use the net proceeds for working capital and general corporate purposes. The transaction is expected to close around Wednesday.Decoy's stock rose 31% in Tuesday trading as intraday volume topped 97.5 million shares, compared with the daily average of 255,339.Price: 3.34, Change: +0.78, Percent Change: +30.51","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","DCOY","BK4139","LENZ","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126714","title":"Why Is Penny Stock Decoy Therapeutics (DCOY) Up 48% Today?","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126714","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126714?lang=en_us&edition=fundamental","pubTime":"2026-09-23 01:10","pubTimestamp":1790097014,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics stock was up 48.05% on Tuesday after the company said it plans to explore Designable Multi-Antivirals for additional candidates.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/why-is-penny-stock-decoy-therapeutics-dcoy-up-48-today?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/why-is-penny-stock-decoy-therapeutics-dcoy-up-48-today?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126509","title":"Decoy Therapeutics, Inc. Announces a Warrant Inducement Transaction for $3.85 Million in Gross Proceeds Priced At-the-Market Under NASDAQ Rules","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126509","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126509?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:51","pubTimestamp":1790095905,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nFWN45E0J4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669265001","title":"NASDAQ Trade Halt Volatility Trading Pause at 12:51 Pm","url":"https://stock-news.laohu8.com/highlight/detail?id=2669265001","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669265001?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:51","pubTimestamp":1790095900,"startTime":"0","endTime":"0","summary":"NASDAQ TRADE HALTVOLATILITY TRADING PAUSE AT 12:51 PM","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nAQN2MKBFH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669126688","title":"Decoy Therapeutics Issues Warrants for 2,368,868 Shares at USD 3.25 Each","url":"https://stock-news.laohu8.com/highlight/detail?id=2669126688","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669126688?lang=en_us&edition=fundamental","pubTime":"2026-09-23 00:51","pubTimestamp":1790095884,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics issues warrants for 2,368,868 shares at USD 3.25 eachDecoy Therapeutics entered a warrant inducement deal for immediate exercise of 1,184,434 Series B Milestone Warrants at $3.25.Ex","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL516p9P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669237741","title":"U.S. Stocks on the MOVE-Greenland Mines, GameStop, Shopify","url":"https://stock-news.laohu8.com/highlight/detail?id=2669237741","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669237741?lang=en_us&edition=fundamental","pubTime":"2026-09-22 23:41","pubTimestamp":1790091697,"startTime":"0","endTime":"0","summary":"BUZZ-U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, ShopifySeptember 22 (Reuters)-The tech-heavy Nasdaq hit an intraday record high for the first time since early June on Tuesday, underpinned by s","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nL6N45E0HJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EAF","VRTX","USNG","SOS","COIN","SLXN","EPD","MARA","BFLY","BTTC","RJF","VLO","VKTX","CLDX","SF","ET","HUT","MRNA","OKE","GEMI","SHPU","DNA","CW","DAVA","GOOGL","RSI","ODDS","SCHW","MSFT","ZEO","AMP","AZO","CMPX","DCOY","KMI","SHOP","FLNA","VICR","GME","AMGN","LEN","THO","GRML","HUBC","RIOT","ONON","CXT","CONY","MLKN","MPWR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669149210","title":"Decoy Therapeutics to explore pan-filovirus program via FDA Animal Rule pathway","url":"https://stock-news.laohu8.com/highlight/detail?id=2669149210","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669149210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:35","pubTimestamp":1790076909,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics (DCOY) announced a corporate strategy to explore its Designable Multi-Antivirals, or D-MAVs, for additional candidates, includin...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-to-explore-pan-filovirus-program-via-fda-animal-rule-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/decoy-therapeutics-to-explore-pan-filovirus-program-via-fda-animal-rule-pathway-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","LABU","BK4585","BK4588","BK4539","DCOY","LENZ","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669499021","title":"Decoy Therapeutics Says Next-Generation D-MAVs Show in Vitro Activity Against Ebola Zaire, Marburg Viruses","url":"https://stock-news.laohu8.com/highlight/detail?id=2669499021","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669499021?lang=en_us&edition=fundamental","pubTime":"2026-09-22 19:30","pubTimestamp":1790076659,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics says next-generation D-MAVs show in vitro activity against Ebola Zaire, Marburg virusesDecoy Therapeutics reported low-micromolar in vitro potency for a de novo filovirus fusion inh","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL1W2bjw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667622972","title":"Decoy Therapeutics Holds Special Shareholder Meeting with Quorum Present","url":"https://stock-news.laohu8.com/highlight/detail?id=2667622972","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2667622972?lang=en_us&edition=fundamental","pubTime":"2026-09-16 05:01","pubTimestamp":1789506092,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics holds special shareholder meeting with quorum presentShareholders met on Sept. 14, 2026 to vote on two capital structure items.Backed issuing common stock upon exercise of Series A,","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260915:nNDL4Xsqwl:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659190093","title":"Decoy Therapeutics Q2 Net Loss Widens 148% to $2.37 Million; Revenue Turns to $227,629 from no Revenue","url":"https://stock-news.laohu8.com/highlight/detail?id=2659190093","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659190093?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:17","pubTimestamp":1786565856,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics Q2 net loss widens 148% to $2.37 million; revenue turns to $227,629 from no revenueDecoy Therapeutics posted a GAAP net loss of $2.37 million for the quarter ended June 30, 2026, wi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nNDL7XSR7P:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657567926","title":"Decoy Therapeutics Announces Special Shareholder Meeting Via Webcast","url":"https://stock-news.laohu8.com/highlight/detail?id=2657567926","media":"Reuters","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657567926?lang=en_us&edition=fundamental","pubTime":"2026-08-05 05:12","pubTimestamp":1785877949,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics announces special shareholder meeting via webcastDecoy Therapeutics will hold a virtual special stockholder meeting on Sept. 14, 2026.Vote scheduled on allowing exercise of Series A","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260804:nNDL39dyNj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656714533","title":"Decoy Therapeutics Expands IP Portfolio with 1 Granted US Patent, 19 Applications Pending","url":"https://stock-news.laohu8.com/highlight/detail?id=2656714533","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656714533?lang=en_us&edition=fundamental","pubTime":"2026-08-03 21:01","pubTimestamp":1785762092,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics expands IP portfolio with 1 granted US patent, 19 applications pendingDecoy Therapeutics expanded its antiviral intellectual property portfolio to seven patent families, including o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nNDL7DHjmc:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391608","title":"Decoy Therapeutics Files Form 3 for Director Patricia G. Gauthier","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391608","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391608?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:52","pubTimestamp":1785531134,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics files Form 3 for director Patricia G. GauthierDecoy Therapeutics reported director Patricia G. Gauthier as a new insider in an initial Form 3 filing dated July 14, 2026.Disclaimer:T","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nNDL6FxNDP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654455048","title":"Decoy Therapeutics D-MAV Candidate Shows in Vitro Activity Against Ebola Zaire Virus","url":"https://stock-news.laohu8.com/highlight/detail?id=2654455048","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654455048?lang=en_us&edition=fundamental","pubTime":"2026-07-27 21:03","pubTimestamp":1785157421,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics D-MAV candidate shows in vitro activity against Ebola Zaire virusDecoy Therapeutics reported a D-MAV candidate showed in vitro activity against wild-type Ebola Zaire in tests at Tex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260727:nNDL870Ldb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","DCOY"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654032655","title":"Decoy Therapeutics Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654032655","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654032655?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:06","pubTimestamp":1784923608,"startTime":"0","endTime":"0","summary":"Decoy Therapeutics announces special shareholder meetingDecoy Therapeutics will hold a virtual special shareholder meeting on Sept. 14, 2026.Vote set on allowing exercise of Series A, Series B, Series","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDLtQYV9:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DCOY","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":42,"code":"91000000","status":"200"}]}}